Profile
Full Name
Seelos Therapeutics, Inc.Ticker Symbol
SEELExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
April 19, 1999Indexes
Not includedEmployees
8Key Details
Price
-
Market cap
-
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$989.44(+62.73% YoY)
PE ratio
-
Next earnings date
N/ANext ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Seelos Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Sep 22, 23 Guggenheim
NeutralSep 21, 23 Guggenheim
NeutralSep 21, 23 Cantor Fitzgerald
NeutralSep 21, 23 Benchmark
Speculative BuyAug 22, 23 Cantor Fitzgerald
OverweightAug 15, 23 Cantor Fitzgerald
OverweightJun 23, 23 Cantor Fitzgerald
OverweightJun 23, 23 Benchmark
Speculative BuyJun 13, 23 BTIG
BuyMay 16, 23 Cantor Fitzgerald
OverweightInstitutional Ownership
Screeners with SEEL included
No data
- What is the ticker symbol for Seelos Therapeutics?
- Does Seelos Therapeutics pay dividends?
- What sector is Seelos Therapeutics in?
- What industry is Seelos Therapeutics in?
- What country is Seelos Therapeutics based in?
- When did Seelos Therapeutics go public?
- Is Seelos Therapeutics in the S&P 500?
- Is Seelos Therapeutics in the NASDAQ 100?
- Is Seelos Therapeutics in the Dow Jones?
- When was Seelos Therapeutics's last earnings report?
- When does Seelos Therapeutics report earnings?
- Should I buy Seelos Therapeutics stock now?
What is the ticker symbol for Seelos Therapeutics?
The ticker symbol for Seelos Therapeutics is NASDAQ:SEEL
Does Seelos Therapeutics pay dividends?
No, Seelos Therapeutics does not pay dividends
What sector is Seelos Therapeutics in?
Seelos Therapeutics is in the Healthcare sector
What industry is Seelos Therapeutics in?
Seelos Therapeutics is in the Biotechnology industry
What country is Seelos Therapeutics based in?
Seelos Therapeutics is headquartered in United States
When did Seelos Therapeutics go public?
Seelos Therapeutics's initial public offering (IPO) was on April 19, 1999
Is Seelos Therapeutics in the S&P 500?
No, Seelos Therapeutics is not included in the S&P 500 index
Is Seelos Therapeutics in the NASDAQ 100?
No, Seelos Therapeutics is not included in the NASDAQ 100 index
Is Seelos Therapeutics in the Dow Jones?
No, Seelos Therapeutics is not included in the Dow Jones index
When was Seelos Therapeutics's last earnings report?
Seelos Therapeutics's most recent earnings report was on Nov 21, 2024
When does Seelos Therapeutics report earnings?
The date for Seelos Therapeutics's next earnings report has not been announced yet
Should I buy Seelos Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions